Expression of the cyclin-dependent kinase inhibitor p16 during the ongoing cell cycle - PubMed (original) (raw)
Comparative Study
. 1995 Oct 9;373(2):164-9.
doi: 10.1016/0014-5793(95)01033-b.
Affiliations
- PMID: 7589458
- DOI: 10.1016/0014-5793(95)01033-b
Free article
Comparative Study
Expression of the cyclin-dependent kinase inhibitor p16 during the ongoing cell cycle
T Soucek et al. FEBS Lett. 1995.
Free article
Abstract
It has been demonstrated that protein expression of p16, the inhibitor of cyclin-dependent kinase 4 and 6, increases 4 fold at the G1/S transition when serum-arrested cells are restimulated to logarithmic growth. We examined the cell cycle regulation of this cyclin-dependent kinase inhibitor in cells separated according to their cell cycle phases by centrifugal elutriation. Neither p16 mRNA nor its protein expression are regulated during the cell cycle of normal phytohemagglutinin-stimulated lymphocytes, retinoblastoma protein-negative cells, papilloma virus-transformed cells, and acute promyelocytic leukemia cells. p16 mRNA is constitutively expressed in cells in which we detected the normal E2F-dependent S-phase specific expression of thymidine kinase mRNA. We further observed a G1-phase specific expression of cyclin D1 mRNA in the same cells separated by centrifugal elutriation.
Similar articles
- The role of p16 in the E2F-dependent thymidine kinase regulation.
Hengstschläger M, Hengstschläger-Ottnad E, Pusch O, Wawra E. Hengstschläger M, et al. Oncogene. 1996 Apr 18;12(8):1635-43. Oncogene. 1996. PMID: 8622883 - Increased expression of the P27KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1.
Doki Y, Imoto M, Han EK, Sgambato A, Weinstein IB. Doki Y, et al. Carcinogenesis. 1997 Jun;18(6):1139-48. doi: 10.1093/carcin/18.6.1139. Carcinogenesis. 1997. PMID: 9214595 - Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein.
Zhu X, Ohtsubo M, Böhmer RM, Roberts JM, Assoian RK. Zhu X, et al. J Cell Biol. 1996 Apr;133(2):391-403. doi: 10.1083/jcb.133.2.391. J Cell Biol. 1996. PMID: 8609171 Free PMC article. - Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.
Khleif SN, DeGregori J, Yee CL, Otterson GA, Kaye FJ, Nevins JR, Howley PM. Khleif SN, et al. Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4350-4. doi: 10.1073/pnas.93.9.4350. Proc Natl Acad Sci U S A. 1996. PMID: 8633069 Free PMC article. - Cyclin kinase inhibitors add a new dimension to cell cycle control.
Yeudall WA, Jakus J. Yeudall WA, et al. Eur J Cancer B Oral Oncol. 1995 Sep;31B(5):291-8. doi: 10.1016/0964-1955(95)00028-3. Eur J Cancer B Oral Oncol. 1995. PMID: 8704644 Review. No abstract available.
Cited by
- Human umbilical cord matrix stem cells maintain multilineage differentiation abilities and do not transform during long-term culture.
Scheers I, Lombard C, Paganelli M, Campard D, Najimi M, Gala JL, Decottignies A, Sokal E. Scheers I, et al. PLoS One. 2013 Aug 9;8(8):e71374. doi: 10.1371/journal.pone.0071374. eCollection 2013. PLoS One. 2013. PMID: 23951150 Free PMC article. - A novel function for the tumor suppressor p16(INK4a): induction of anoikis via upregulation of the alpha(5)beta(1) fibronectin receptor.
Plath T, Detjen K, Welzel M, von Marschall Z, Murphy D, Schirner M, Wiedenmann B, Rosewicz S. Plath T, et al. J Cell Biol. 2000 Sep 18;150(6):1467-78. doi: 10.1083/jcb.150.6.1467. J Cell Biol. 2000. PMID: 10995450 Free PMC article. - Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts.
Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC. Alcorta DA, et al. Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13742-7. doi: 10.1073/pnas.93.24.13742. Proc Natl Acad Sci U S A. 1996. PMID: 8943005 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials